Stock Research for PTCT


Featured Broker: Ally Invest

Get the due diligence for another stock.


PTCT Stock Chart & Research Data

The PTCT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PTCT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PTCT Due diligence Resources & Stock Charts

The PTCT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PTCT Detailed Price Forecast - CNN Money CNN View PTCT Detailed Summary - Google Finance
Yahoo View PTCT Detailed Summary - Yahoo! Finance Zacks View PTCT Stock Research & Analysis -

Stock Analysis

TradeIdeas View PTCT Trends & Analysis - Trade-Ideas Barrons View PTCT Major Holders - Barrons
NASDAQ View PTCT Call Transcripts - NASDAQ Seeking View PTCT Breaking News & Analysis - Seeking Alpha
Spotlight View PTCT Annual Report - OTC Report View PTCT OTC Short Report -
TradeKing View PTCT Fundamentals - TradeKing Charts View PTCT SEC Filings - Bar Chart
WSJ View Historical Prices for PTCT - The WSJ Morningstar View Performance/Total Return for PTCT - Morningstar
MarketWatch View the Analyst Estimates for PTCT - MarketWatch CNBC View the Earnings History for PTCT - CNBC
StockMarketWatch View the PTCT Earnings - StockMarketWatch MacroAxis View PTCT Buy or Sell Recommendations - MacroAxis
Bullish View the PTCT Bullish Patterns - American Bulls Short Pains View PTCT Short Pain Metrics -

Social Media Mentions

StockTwits View PTCT Stock Mentions - StockTwits PennyStocks View PTCT Stock Mentions - PennyStockTweets
Twitter View PTCT Stock Mentions - Twitter Invest Hub View PTCT Investment Forum News - Investor Hub
Yahoo View PTCT Stock Mentions - Yahoo! Message Board Seeking Alpha View PTCT Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PTCT - Insider Cow View Insider Transactions for PTCT - Insider Cow
CNBC View PTCT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PTCT - OTC Markets
Yahoo View Insider Transactions for PTCT - Yahoo! Finance NASDAQ View Institutional Holdings for PTCT - NASDAQ

Stock Charts

FinViz View PTCT Stock Insight & Charts - StockCharts View PTCT Investment Charts -
BarChart View PTCT Stock Overview & Charts - BarChart Trading View View PTCT User Generated Charts - Trading View

Latest Financial News for PTCT

PTC Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
Posted on Thursday April 12, 2018

SOUTH PLAINFIELD, N.J. , April 12, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today that the underwriters of its previously announced public offering of 4,000,000 shares of its ...

PTC Therapeutics Announces R&D Day to Review Multiple Orphan Disorder Programs
Posted on Monday April 09, 2018

SOUTH PLAINFIELD, N.J. , April 9, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that it will hold its R&D Day on Tuesday, April 17, 2018 from 12:00 p.m. to 5:00 p.m. ET in New York ...

PTC Therapeutics and CHDI Foundation Announce a Collaboration on a Small-Molecule Therapeutic for Huntington's Disease
Posted on Wednesday April 04, 2018

SOUTH PLAINFIELD, N.J., April 4, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) and the CHDI Foundation, Inc. (CHDI) today announced a research collaboration to advance PTC's Huntington's disease program. The program is optimizing small-molecule compounds—identified using PTC's splicing technology platform—that decrease the production of huntingtin protein. The current compounds have been shown to be orally bioavailable in animals, blood-brain barrier penetrant, and effective in decreasing the amount of huntingtin protein in a mouse model that has the expanded human huntingtin transgene.

PTC Therapeutics Announces Pricing of Public Offering of Common Stock
Posted on Wednesday March 28, 2018

In addition, PTC has granted the underwriters an option for a period of 30 days to purchase up to an additional 600,000 shares of common stock at the public offering price, less the underwriting discount. Credit Suisse and Citigroup are acting as lead book-running managers for the offering. RBC Capital Markets is also acting as a book-running manager.

Enter a stock symbol to view the stock details.